Aptiom and Phenytoin may both be anticonvulsants, yet they have many points of contrasting variation which exemplify their individual advantages and disadvantages. For example, they have differing amounts of clinical research, drug therapy regimen variance, and cost differences that make the each drug distinct and highly distinguishable from the other. Phenytoin was first synthesized in 1908 and was approved by the FDA in 1939 (Ogbru, n.d). Since then, it has become one of the most commonly used…